Exelon (EXC) — insider trading
Utilities
Exelon (EXC) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | BOWERS WILLIAM P | Director | Grant / award / vesting (derivative) | 925 | $46.62 | $43.1K | Form 4 |
| 2026-06-30 | Cheshire Marjorie Rodgers | Director | Grant / award / vesting (derivative) | 442 | $46.62 | $20.6K | Form 4 |
| 2026-06-30 | Lillie Charisse R | Director | Grant / award / vesting (derivative) | 5 | $46.62 | $233 | Form 4 |
| 2026-06-30 | Rogers Matthew C | Director | Grant / award / vesting (derivative) | 778 | $46.62 | $36.3K | Form 4 |
| 2026-04-28 | BOWERS WILLIAM P | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | Cheshire Marjorie Rodgers | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | DEWALT DAVID G | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | Jojo Linda P | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | Lillie Charisse R | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | RICHO ANNA | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | Rogers Matthew C | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
| 2026-04-28 | Segedi Bryan K | Director | Grant / award / vesting (derivative) | 3,720 | $0.00 | $0 | Form 4 |
Ask the chat about EXC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Exelon (EXC).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.